QS Investors, LLC - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 213 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$95,000
-52.3%
4,000
-45.9%
0.00%
-50.0%
Q3 2019$199,000
-1.0%
7,4000.0%0.00%0.0%
Q2 2019$201,000
+191.3%
7,400
+184.6%
0.00%
+100.0%
Q3 2018$69,000
-30.3%
2,600
-0.4%
0.00%0.0%
Q2 2018$99,000
+16.5%
2,6110.0%0.00%0.0%
Q1 2018$85,000
-33.1%
2,6110.0%0.00%0.0%
Q4 2017$127,000
-9.9%
2,6110.0%0.00%0.0%
Q3 2017$141,000
-4.1%
2,6110.0%0.00%0.0%
Q2 2017$147,000
+14600.0%
2,611
+23636.4%
0.00%
Q2 2016$1,0000.0%11
-50.0%
0.00%
Q1 2016$1,0000.0%22
+266.7%
0.00%
Q4 2015$1,00060.00%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 228,873$7,475,0004.17%
PFM Health Sciences, LP 5,326,671$173,969,0003.54%
Marcus Capital, LLC 22,950$750,0002.76%
Partner Investment Management, L.P. 72,284$2,361,0002.55%
CADIAN CAPITAL MANAGEMENT, LP 1,240,944$40,529,0002.19%
HARVEY CAPITAL MANAGEMENT INC 158,580$5,179,0001.94%
SECTORAL ASSET MANAGEMENT INC 498,412$16,278,0001.78%
Everett Capital Advisors UK LLP 551,173$18,001,0001.52%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 125,210$4,089,0001.46%
Atika Capital Management LLC 113,000$3,691,0001.26%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders